Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.5. rezultāts no 100.
vi. lappuse
... reference ? Incorporation by reference was established by statute and allows Federal agencies to meet the requirement to publish regu- lations in the Federal Register by referring to materials already published else- where . For an ...
... reference ? Incorporation by reference was established by statute and allows Federal agencies to meet the requirement to publish regu- lations in the Federal Register by referring to materials already published else- where . For an ...
70. lappuse
... reference . A reference to information submitted previously must identify the file by name , reference number , volume , and page number where the information can be found . A reference to information submitted to the agency by a person ...
... reference . A reference to information submitted previously must identify the file by name , reference number , volume , and page number where the information can be found . A reference to information submitted to the agency by a person ...
72. lappuse
... reference ( date and number ) to the submission that contained the proto- col . ( iii ) In the case of a new investigator , the investigator's name , the qualifica- tions to conduct the investigation , ref- erence to the previously ...
... reference ( date and number ) to the submission that contained the proto- col . ( iii ) In the case of a new investigator , the investigator's name , the qualifica- tions to conduct the investigation , ref- erence to the previously ...
102. lappuse
... Reference listed drug means the listed drug identified by FDA as the drug product upon which an applicant relies in seeking approval of its abbreviated application . Right of reference or use means the au- thority to rely upon , and ...
... Reference listed drug means the listed drug identified by FDA as the drug product upon which an applicant relies in seeking approval of its abbreviated application . Right of reference or use means the au- thority to rely upon , and ...
104. lappuse
... Reference to the current edition of the U.S. Pharmacopeia and the National Formulary may satisfy relevant requirements in this para- graph . ( ii ) ( a ) Drug product . A list of all com- ponents used in the manufacture of the drug ...
... Reference to the current edition of the U.S. Pharmacopeia and the National Formulary may satisfy relevant requirements in this para- graph . ( ii ) ( a ) Drug product . A list of all com- ponents used in the manufacture of the drug ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning